RFK, Jr., puts psychedelics on fast track to FDA review and approval
April 24, 2026 2 min read Add Us On GoogleAdd SciAm RFK, Jr., puts psychedelics on fast track to FDA review and approval The U.S. Food and Drug Administration is seeking to accelerate the review process for three companies that are studying psilocybin and an MDMA-like drug as treatments for depression and PTSD By Claire…
